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Background. During the first half of 2014, a severe outbreak of measles occurred in northern Vietnam, causing 15 033 con-
firmed cases and 146 deaths. 
Methods. To evaluate the population-level seroprevalence of protection against measles in the period before the outbreak, 
we made use of an existing age-stratified serum bank, collected over the year before the outbreak, between November 2012 and 
December 2013, from 4 sites across the country (Hanoi, Hue, Dak Lak, and Ho Chi Minh City). Data from the UNICEF’s Multiple 
Indicator Clustered Surveys (MICS), carried out in Vietnam during the first quarter of 2014, were used to assess the vaccine coverage 
in 6 ecological regions of Vietnam. 
Results. Results revealed a large discrepancy between levels of protection, as estimated from the serology and vaccine coverage 
estimated by UNICEF’s MICS. Variation in seroprevalence across locations and age groups corresponded with reported numbers of 
measles cases, most of which were among the 0–2-year-old age group and in the northern part of the country. 
Conclusions. Our study presents a strong case in favor of a serosurveillance sentinel network that could be used to proactively 
tune vaccination policies and other public health interventions.
Keywords. measles; seroprevalence; vaccination; Vietnam.
Measles is a highly transmissible infection that causes high 
morbidity and mortality, particularly in malnourished or oth-
erwise compromised children [1–3]. In the prevaccination era, 
more than 90% of individuals contracted the disease by the age 
of 10 [4]. Since the initiation of the Expanded Programme on 
Immunization (EPI) in 1974 by World Health Organization 
(WHO), the worldwide incidence of measles has substantially 
declined [5]. In 2000, pursuing the goal of global measles erad-
ication, the WHO prioritized vaccination campaigns in the 45 
countries that together accounted for more than 90% of esti-
mated global measles deaths [6]. The WHO strategy for measles 
reduction is based on achieving vaccine coverage of >90% for 
2 doses of vaccine, delivered at 9 and 18 months [3, 7]. About 
15% of children injected with a single dose of a measles virus–
containing vaccine (MCV) at the age of 9 months fail to develop 
immunity [6, 8, 9]. A second dose at the age of 18 months is thus 
necessary and confers approximately 98% protection [9, 10].
Despite the efforts deployed toward global eradication, mea-
sles remains a leading cause of vaccine-preventable childhood 
mortality in developing countries, with the greatest incidence 
occurring in children younger than 2  years of age [11–13]. 
Measles has recently re-emerged in a number of countries in 
Europe and North America due to refusal to vaccinate [14]. 
Insufficient vaccine uptake has been identified as the main cause 
of re-emergence [15]. The resilient circulation of misinforma-
tion regarding associations between vaccination and autism and 
other adverse events, against a backdrop of perceived decreased 
hazard of measles due to successful reductions in transmission 
[16], is a major impediment to maintaining high vaccination 
rates [17, 18]. As measles is highly infectious—with R0 estimates 
between 12 and 18, depending on the population considered 
[19]—a small proportion of seronegative (unprotected) individ-
uals could be sufficient to start and sustain an epidemic [11, 20].
Vietnam is 1 of the 45 countries that implements the WHO’s 
EPI. Despite high officially reported vaccination coverage rates, 
Vietnam experienced a severe measles outbreak in 2014 (more 
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than 15  033 confirmed cases and 146 fatalities) [21], despite 
high official vaccine coverages (>90% for all provinces and 
>95% for most of them). During the 2014 outbreak, most chil-
dren admitted to hospitals with measles infection were younger 
than 12 months, and many were therefore not fully vaccinated. 
However, even among children older than 12 months who pre-
sented to hospitals with measles, a large proportion did not have 
a history of vaccination. The epidemic appeared to be more 
severe in the north of the country, with 763 reported cases in 
Ho Chi Minh City (south, official population 8.4 million), vs 
4216 in the capital city of Hanoi (north, official population 3.4 
million).
Here, we aimed to estimate the vaccine coverage and serum 
protection levels by age and region just before the 2014 epidemic, 
in order to assess whether any of these estimates is more in ac-
cordance with the observed magnitude of the epidemic than the 
official vaccine coverage numbers. Population protection levels 
were estimated from an existing age-stratified serum bank that 
had been collected between November 2012 and December 
2013 from 4 hospitals across Vietnam. Vaccination coverages 
were estimated in 6 regions of Vietnam from the immunization 
data from the UNICEF Multiple Indicators Clustered Survey 
(MICS), conducted in Vietnam in 2014 (General Statistical 
Office and UNICEF 2015).
METHODS
Serum Samples Collection
The National Institute for Hygiene and Epidemiology initi-
ated a serum biobank project in 2012, comprising periodic 
age-stratified residual serum collections from 4 hospitals 
in Vietnam (Thanh Nhan Hospital in Hanoi, Hue Central 
Hospital in the city of Hue [central coastal region]), Dak Lak 
General Hospital in the central highlands city of Buon Ma 
Thuot, and Gia Dinh People’s Hospital in Ho Chi Minh City 
(Figure 1A). We used a total of 3662 serum samples from this 
biobank, representing children and women of childbearing 
age. Our sampling protocol was based on recommendations 
from the European Sero-Epidemiology Network (ESEN), 
which suggests testing at least 50 samples per gender and 
suggests a 1-year age band for individuals younger than 20 
and a 5-year age band for individuals older than 20 [22]. 
Given that most measles cases in the 2014 Vietnam out-
break were infants and children, we focused our testing on 
the younger age classes and aimed at testing 50 samples per 
gender with a 1-year age band for individuals younger than 
10 years old. In addition, we tested serum from women of 
childbearing age, using 50 samples per 1-year age band from 
age 16 to 20 years and 100 samples per 5-year age band from 
age 20 to 35 years.
Incidence
Line listing incidence data of confirmed cases were retrieved 
from the WHO EPI in Vietnam and aggregated by province, 
gender, age, and week.
Serology
Measles IgG ELISA assays (SERION Immunologics, Würzburg, 
Germany) were conducted on all subsampled sera according 
to the manufacturer’s instructions [23]. The test used 10 µL of 
serum, and titers were expressed in IU/L based on quantitative 
spectrophotometry at 620–690 nm. Titers <200 IU/L indicated 
susceptibility; titers >275 IU/L indicated protection; interme-
diate titers were designated equivocal. To counter the difficul-
ties in the analysis of equivocal results, analyses were conducted 
using both thresholds. Reported sensitivity and specificity of 
the assay were 99% and 93%, respectively, according to the 
manufacturer.
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Figure 1. A, Map showing locations of the 4 sampled hospitals in Vietnam: Hanoi, Hue, Dak Lak, and Ho Chi Minh City. B, Weekly measles notifications for the 2014 epi-
demic in Vietnam. Gray dots show the timing of serum sampling in the 4 sampling sites (see Supplementary Figure 1 for more details), the two vertical lines show the timing 
of the UNICEF Multiple Indicator Clustered Surveys.
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Population Protection
Percentages of immunized people per location, gender, and age 
class were derived from IgG levels, considering both the 200- 
and 275-IU/L thresholds. Effects of age class and location (and 
gender when possible), as well as interactions between age and 
location (and age and gender when possible), on the percent-
ages of immunized individuals were modeled by multivariate 
logistic regressions with a logit link [24]. Age bands were coded 
as factors (instead of numeric variables) in order to favor flex-
ibility in the relationship between age and seroprevalence (at 
the risk of lower statistical power). Statistical significance was 
assessed by likelihood ratio tests (LRTs) in order to control for 
potential confounding effects [25] that may persist despite our 
efforts for a balanced sampling scheme (Supplementary Figure 
2 and Supplementary Table 1). For both the 200- and 275-IU/L 
thresholds used to calculate seroprevalence, the model was 
run twice: once on all the data and once on the under-10 age 
classes. In the first case, gender was not introduced as a covari-
ate, whereas gender and age × gender interactions were intro-
duced as covariates in the second case. All the analyses were 
performed in R, version 3.3.2 [26].
Vaccination Coverage
The UNICEF MICS is a stratified clustered survey. The strata 
are the urban and rural areas within the 6 ecological regions of 
Vietnam (12 strata in total). Within each stratum, a number of 
census enumeration areas (considered clusters) was randomly 
selected with probability proportional to size (510 selected 
enumeration areas in total), and within each enumeration area, 20 
households were drawn at random. Household interviews using 
structured questionnaires were completed between December 
16, 2013, and April 5, 2014. Questions were asked on different 
topics, including immunization. After the UNICEF protocol, the 
vaccine coverage was computed from the answers to questions 
M3MD, IM16, and HF13MD regarding, respectively, (1) the day 
of measles vaccination from the immunization card, (2) measles 
vaccination information reported by the mother, and (3) the day 
of measles vaccination from the health facility. Immunization 
data were only available for children below the age of 3  years. 
See the Supplementary Data for more details on the questions 
(Supplementary Tables 2–4) and the algorithm. Analyses were 
performed with the survey R package, version 3.33-2 [27].
RESULTS
The numbers of collected samples per location, gender, and age 
class are shown in Supplementary Table 1 and Supplementary 
Figure 2. Supplementary Figure 1 further shows the times of 
sample collections in the 4 locations. Given that the 2014 ep-
idemic occurred during the first 6 months of 2014, our sam-
ples give a snapshot of the situation during the 12 months that 
preceded the epidemic (Figure 1B). Most of the cases recorded 
by the WHO EPI occurred among infants and young children 
(38% of cases below the age of 1  year and 11% of cases age 
1–2 years) (Supplementary Figure 3) and in northern Vietnam 
(4216 cases in the province of Hanoi only) (Figure 2).
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Figure 2. A, B, Population size (A) and density (B) for Vietnam as from the 2009 population and housing census [34]. C, D, Incidence (C) and incidence rate (incidence divided 
by population size) (D) for the 2014 epidemic, as reported by the World Health Organization’s Expanded Programme on Immunization. Yellow triangles show the 4 serum 
sampling sites of 2013 (Figure 1A).
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Table 1 summarizes the results of the likelihood ratio tests on 
the effects of covariates and interactions in the logistic regres-
sions, considering the 2 density thresholds (200 and 275 IU/L) 
and the 2 age ranges (all ages and under 10 years old). These 
models show strong age and location effects and an absence of 
gender effects. Furthermore, there are significant age × location 
interactions, except when considering the 275-IU/L threshold 
for children under 10.
Figure 3 illustrates the relationships between estimated lev-
els of seroprevalences and age for the 4 locations (by column) 
and the 2 thresholds (by row). The shapes of the relationships 
were qualitatively similar for the 2 thresholds, as well as for 
the 4 locations: increase in seroprevalence with age for the age 
classes 0–1, 1–2, and 2–3, stabilization of seroprevalence lev-
els until the age of 10 years, slight decrease during the teenage 
years and increase again in the early 20s, after which seroprev-
alences reach levels above 90% (after 25  years old) and 95% 
(after 30 years old). There were, however, some large quantita-
tive differences between the 4 locations: Hanoi and Hue show 
particularly low levels of seroprevalence for the age bands 0–1 
and 1–2 (particularly low for the 1–2-year-old age class in Hue). 
Such extremely low levels of prevalence (approximately 50%) 
for these age bands were not observed in Dak Lak or Ho Chi 
Minh City, where the levels were closer to 70%. Seroprevalence 
for the 16–17 age band was particularly low in Ho Chi Minh 
City, and seroprevalence for the 16–19 age bands was particu-
larly high in Dak Lak.
The estimates of population protection for the age classes <3 
are extracted from Figure 3 and shown in Figure 4 (with white 
background, with thresholds 275 IU/L [bottom] and 200 IU/L 
[top]), together with the estimates of vaccine coverages from the 
UNICEF MICS (with a colored background mapping the 6 dif-
ferent regions of Vietnam), also for the age classes <3. Estimates 
of vaccine coverages are made separately for the rural (bottom) 
and urban (top) areas. This figure shows that seroprotection in 
the age class <1 (between 40% and 60%) is much higher than 
what can be expected from vaccination (25%, given a first shot 
at 9 months), even accounting for a vaccine efficacy of 85% for 
the first shot, probably due to maternal immunity in the first 
few months of life. On the contrary, vaccine coverage for this 
age class (around 10%) is much lower than the expected 25%. 
Looking at the 2 other age classes, it appears that vaccine cov-
erages are quite high (around 95%), which is inconsistent with 
the corresponding observed levels of seroprevalence (between 
50% and 80%).
DISCUSSION
The data revealed an overall very low level of protection in the 
4 study sites, with seroprevalence between 40% and 80% for 
children younger than age 5 years and levels of seroprevalence 
reaching 90% and 95% for ages 25 and 30 years, respectively. 
Such levels of protection were not adequate to provide efficient 
protection against epidemic measles transmission; previous 
modeling efforts have consistently recommended a minimum 
of 95% immunization to achieve herd immunity [19]. For the 
0–1-year age class, the vaccination coverages estimated from 
the UNICEF MICS data are in line with the levels of population 
protection estimated from our serum bank, taking into account 
that the first vaccine dose is injected at the age of 9  months 
and that maternal immunity confers protection until the age of 
6 months [28]. For the other age classes, however, our results 
highlight a marked discrepancy between the estimated levels 
of population protection (60%–70%) and vaccine coverages 
(90%–95%). The exact cause of this discrepancy is unknown 
and would require further in-depth investigation that is beyond 
the scope of this study.
Identifying the precise causes of the discrepancy between 
officially reported vaccine coverage rates and our estimated 
levels of protection is a priority to improve current immuniza-
tion programs in Vietnam. Further specific investigations are 
needed to examine both the logistics and quality control of vac-
cine distribution, especially in regards to cold chain [29] and 
immune responses of vaccination [28]. However, whatever the 
causes of the discrepancy between reported vaccine coverage 
rates and our estimates of population immune protection, our 
results indicate that estimates of vaccine coverages like UNICEF 
Table 1. Likelihood Ratio Tests of the Effects of Covariates and Interactions (“x”) in the Logistic Regressions Explaining Seroprevalence, Considering the 
200 and 275 IU/L Thresholds and Stratified by Age <10 Years or for All Ages
 
 
 
 
 
df
200 IU/L 275 IU/L
Deviance P (>chi) Deviance P (>chi)
Age <10 y Location 3 25.989 <2 × 10-16 20.172 .0002
Gender 1 0.074 .7861 1.272 .2593
Age 9 54.181 <2 × 10-16 44.348 <2 × 10-16
Location × age 27 44.060 .0204 35.697 .1221
Gender × age 9 9.761 .3702 10.017 .3491
All ages Location 3 25.599 <2 × 10-16 27.340 <2 × 10-16
Age 16 283.472 <2 × 10-16 286.606 <2 × 10-16
Location × age 48 91.853 .0001 79.733 .0027
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MICS are poor predictors of the actual population protection. 
Measles being extremely contagious (R0 between 12 and 18), 
complete eradication remains a very difficult target in many 
countries. A number of strategies have been explored recently 
to improve the efficacy of vaccination campaigns. Outbreak 
response vaccination (ORV), for example, is a case-triggered 
policy that has been proposed based on the fact that measles 
vaccination can confer immunity shortly after injection and 
even mitigate the disease severity and transmission in subjects 
already infected [30–32]. A recent theoretical study proposes to 
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Figure 3. Estimated levels of seroprevalence (circles) together with 95% confidence intervals (error bars) by age class in years (x-axes) for the 200- and 275-IU/L thresholds 
(first and second rows, respectively) for the 4 locations (by columns). Vertical dashed gray lines show the age classes.
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Figure 4. Population protection and vaccine coverage against measles in 2013–2014. The map on the left shows the 6 ecological regions of Vietnam, color-coded, together 
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bottom to top (see the legend on the right). For the seroprevalence estimates, both the 275-IU/L (bottom) and 200-IU/L (top) thresholds are shown for each age class. For the 
vaccine coverage estimates, both the rural (bottom) and urban (top) strata are shown for each age class.
D
ow
nloaded from
 https://academ
ic.oup.com
/ofid/article-abstract/6/3/ofz030/5299782 by R
adboud U
niversity user on 06 M
ay 2019
6 • ofid • Choisy et al
go a step further in planning vaccination campaigns triggered 
not only by incidence but also by population seroprevalence, 
thus aiming to prevent outbreaks before they start [33]. The 
results of this study show that small-scale serological surveil-
lance can greatly improve the efficacy of vaccination policies in 
low-incidence contexts (in high-incidence contexts, classical 
case-triggered strategies remain more efficient). In the context 
of Vietnam, where incidence levels overall remain low, a serolo-
gy-based surveillance system could be the ideal complement to 
the current vaccination strategy, especially in light of our results 
showing that vaccine coverage does not provide dependable 
information on true population protection. Given this, a cost–
benefit analysis of a serosurveillance sentinel network would be 
of great use.
The lowest levels of protection against measles virus were 
observed for the classes 0–1 and 1–2 in the 2 northern sites 
of our study. This is an interesting result given that half of the 
measles cases reported in the 2014 epidemic were very young 
(0–2 years old), and 90% of them were from the northern part 
of the country. Unfortunately, in the absence of information on 
the geographical origin of the patients from which the samples 
were taken, a direct relationship between seroprevalence and 
incidence is difficult to establish. Furthermore, the 4 sampling 
sites of the study happen by chance to be located in provinces of 
high incidence (Figure 3D), making such a relationship between 
seroprevalence and incidence even more difficult to unravel.
Two other details of the age–seroprevalence profiles observed 
in our study are the slow decrease of seroprevalence with age 
among teenagers and the fast increase of seroprevalence around 
the age of 20. As our seroepidemiological study is cross-sec-
tional, it does not allow us to know whether the decrease of sero-
prevalence observed among teenagers is due to past increases 
in vaccine coverage or to some effect of waning immunity. 
Longitudinal data from a serosurveillance sentinel network 
would address questions such as these, thus, again, efficiently 
improving the development of vaccination and elimination 
strategies. As for the fast increase of seroprevelance around the 
age of 20 years, a likely explanation is the pre-wedding health 
checks that are routinely performed in Vietnam, which include 
updates of vaccination status.
Our logistic models show clear differences in seroprevalence 
by age and geographic location. The results confirm that our 
choice of sample size for each age class was adequately powered 
to detect effects. They also confirm that our sampling scheme 
was sufficiently balanced (despite a slight under-representation 
of females in Ho Chi Minh City) (Supplementary Table 1 and 
Supplementary Figure 2), as the LRT corrections for potential 
confounding effects did not lead to different conclusions from 
those not using corrections (results not shown).
In conclusion, our results suggest that a surveillance net-
work of the levels of population protection based on the use 
of hospital residual serum samples could greatly improve the 
anticipation of epidemic risk and thus prevent epidemic by 
allowing for timely and adequately targeted (by age and loca-
tion) interventions.
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